Can pain can be more or less neuropathic? Comparison of symptom assessment tools with ratings of certainty by clinicians

被引:115
作者
Bennett, MI [1 ]
Smith, BH
Torrance, N
Lee, AJ
机构
[1] Univ Leeds, St Gemmas Hospice, Clin Teaching & Res Unit, Leeds, W Yorkshire, England
[2] Univ Aberdeen, Dept Gen Practice & Primary Care, Aberdeen, Scotland
关键词
neuropathic pain; clinical assessment; diagnostic tools; S-LANSS;
D O I
10.1016/j.pain.2006.02.002
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Chronic pain is generally regarded as being divided into two mutually exclusive pain mechanisms: nociceptive and neuropathic. Recently, this dichotomous approach has been questioned and a model of chronic pain being 'more or less neuropathic' has been suggested. To test whether such a spectrum exists, we examined responses by patients with chronic pain to validated neuropathic pain assessment tools and compared these with ratings of certainty about the neuropathic origin of pain by their specialist pain physicians. We examined 200 patients (100 each with nociceptive and neuropathic pain) and administered the self-complete Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS score) and the Neuropathic Pain Scale (NPS). Clinicians were asked to rate their certainty of the presence of neuropathic pain mechanisms on a 100 mm visual analogue scale (VAS) (0 = 'not at all neuropathic in origin' to 100 = 'completely neuropathic in origin'). The whole sample was divided into tertiles based on ascending ratings of diagnostic certainty by clinicians using the VAS and labelled 'unlikely', 'possible' and 'definite' neuropathic pain. There were significant differences in median S-LANSS and NPS composite scores between all tertile groups. There were also significant differences between many S-LANSS and NPS item scores between groups. We have shown that higher scores on both the S-LANSS and the NPS are indicative of greater clinician certainty of neuropathic pain mechanisms being present. These data support the theoretical construct that pain can be more or less neuropathic and that pain of predominantly neuropathic origin may be a useful clinical concept. (c) 2006 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:289 / 294
页数:6
相关论文
共 17 条
  • [1] Can pain be more or less neuropathic?
    Attal, N
    Bouhassira, D
    [J]. PAIN, 2004, 110 (03) : 510 - 511
  • [2] Defining neuropathic pain
    Backonja, MM
    [J]. ANESTHESIA AND ANALGESIA, 2003, 97 (03) : 785 - 790
  • [3] Neuropathic pain: A crisis of definition?
    Bennett, GJ
    [J]. ANESTHESIA AND ANALGESIA, 2003, 97 (03) : 619 - 620
  • [4] The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs
    Bennett, M
    [J]. PAIN, 2001, 92 (1-2) : 147 - 157
  • [5] The S-LANSS score for identifying pain of predominantly neuropathic origin: Validation for use in clinical and postal research
    Bennett, MI
    Smith, BH
    Torrance, N
    Potter, J
    [J]. JOURNAL OF PAIN, 2005, 6 (03) : 149 - 158
  • [6] Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4)
    Bouhassira, D
    Attal, N
    Alchaar, H
    Boureau, F
    Brochet, B
    Bruxelle, J
    Cunin, G
    Fermanian, J
    Ginies, P
    Grun-Overdyking, A
    Jafari-Schluep, H
    Lantéri-Minet, M
    Laurent, B
    Mick, G
    Serrie, A
    Valade, D
    Vicaut, E
    [J]. PAIN, 2005, 114 (1-2) : 29 - 36
  • [7] The lidocaine patch 5% effectively treats all neuropathic pain qualities: Results of a randomized, double-blind, vehicle-controlled, 3-week efficacy study with use of the Neuropathic Pain Scale
    Galer, BS
    Jensen, MP
    Ma, T
    Davies, PS
    Rowbotham, MC
    [J]. CLINICAL JOURNAL OF PAIN, 2002, 18 (05) : 297 - 301
  • [8] Development and preliminary validation of a pain measure specific to neuropathic pain: The neuropathic pain scale
    Galer, BS
    Jensen, MP
    [J]. NEUROLOGY, 1997, 48 (02) : 332 - 338
  • [9] Morphine, gabapentin, or their combination for neuropathic pain
    Gilron, I
    Bailey, JM
    Tu, DS
    Holden, RR
    Weaver, DF
    Houlden, RL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (13) : 1324 - 1334
  • [10] Assessment and treatment of neuropathic cancer pain following WHO guidelines
    Grond, S
    Radbruch, L
    Meuser, T
    Sabatowski, R
    Loick, G
    Lehmann, KA
    [J]. PAIN, 1999, 79 (01) : 15 - 20